Conformational requirements for vascular alpha-adrenergic activity.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000818:Animals; D001011:Aorta / Q000187:drug effects; D003846:Deoxyepinephrine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D066298:In Vitro Techniques; D008968:Molecular Conformation; D009119:Muscle Contraction / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology; D013237:Stereoisomerism; D013764:Tetrahydronaphthalenes / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D013764:Tetrahydronaphthalenes; D012110:Reserpine; D003846:Deoxyepinephrine; D004298:Dopamine; D009638:Norepinephrine